Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Filson

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
JAMA Network Open|June 14, 2024
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data LinkageMichael S Leapman, Julian Ho, Yang Liu, et al.
Cancer|July 12, 2022
Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesionsAndrew M Fang, Luke A Shumaker, Kimberly D Martin, et al.
The Journal of Urology|July 30, 2017
Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized TrialDonna L Berry, Fangxin Hong, Traci M Blonquist, et al.
European Urology Open Science|March 4, 2022
Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate CancerBenjamin W Fischer-Valuck, Brian C Baumann, Simon A Brown, et al.
Brachytherapy|July 7, 2020
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancerBenjamin W Fischer-Valuck, Yuan James Rao, Randall J Brenneman, et al.
Urologic Oncology|December 23, 2020
Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trialDonna L Berry, Fangxin Hong, Traci M Blonquist, et al.
Urology Practice|May 5, 2023
Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Lisa Newcomb, et al.
Nutrition and Cancer|November 7, 2022
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance StudyJeannette M Schenk, Menghan Liu, Marian L Neuhouser, et al.
The Journal of Urology|April 29, 2020
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance StudyMichael A Liss, Lisa F Newcomb, Yingye Zheng, et al.
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
JAMA Network Open|June 14, 2024
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data LinkageMichael S Leapman, Julian Ho, Yang Liu, et al.
Cancer|July 12, 2022
Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesionsAndrew M Fang, Luke A Shumaker, Kimberly D Martin, et al.
The Journal of Urology|July 30, 2017
Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized TrialDonna L Berry, Fangxin Hong, Traci M Blonquist, et al.
European Urology Open Science|March 4, 2022
Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate CancerBenjamin W Fischer-Valuck, Brian C Baumann, Simon A Brown, et al.
Brachytherapy|July 7, 2020
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancerBenjamin W Fischer-Valuck, Yuan James Rao, Randall J Brenneman, et al.
Urologic Oncology|December 23, 2020
Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trialDonna L Berry, Fangxin Hong, Traci M Blonquist, et al.
Urology Practice|May 5, 2023
Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Lisa Newcomb, et al.
Nutrition and Cancer|November 7, 2022
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance StudyJeannette M Schenk, Menghan Liu, Marian L Neuhouser, et al.
The Journal of Urology|April 29, 2020
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance StudyMichael A Liss, Lisa F Newcomb, Yingye Zheng, et al.
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Pageof 13